152 related articles for article (PubMed ID: 6642645)
1. Stimulation of complement production in mice by N alpha-(N-acetylmuramyl-L-alanyl-D-isoglutamine)-N epsilon-stearoyl-L-lysine.
Endo N; Okuda T; Osada Y; Zen-Yoji H
Infect Immun; 1983 Nov; 42(2):618-22. PubMed ID: 6642645
[TBL] [Abstract][Full Text] [Related]
2. [Restoration by N alpha-(N-acetylmuramyl-L-alanyl-D-isoglutamine)-N epsilon-stearoyl-L-lysine from the decomplement state in mice induced by cobra venom factor, followed by acquisition of resistance to bacterial infections].
Okuda T; Endo N; Zen-Yoji H; Osada Y
Kansenshogaku Zasshi; 1986 Mar; 60(3):204-9. PubMed ID: 3095445
[No Abstract] [Full Text] [Related]
3. Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide.
Phillips NC; Rioux J; Tsao MS
Hepatology; 1988; 8(5):1046-50. PubMed ID: 2971013
[TBL] [Abstract][Full Text] [Related]
4. Effect of stearoyl-N-acetylmuramyl-L-alanyl-D-isoglutamine on host resistance to Corynebacterium kutscheri infection in cortisone-treated mice.
Ishihara C; Yamamoto K; Hamada N; Azuma I
Vaccine; 1984 Dec; 2(4):261-4. PubMed ID: 6531965
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo augmentation by muroctasin of the production of the third component of complement by murine macrophages.
Endo N
Arzneimittelforschung; 1988 Jul; 38(7A):993-6. PubMed ID: 3190805
[TBL] [Abstract][Full Text] [Related]
6. Polymorphonuclear leukocyte activation by a synthetic muramyl dipeptide analog.
Osada Y; Otani T; Sato M; Une T; Matsumoto K; Ogawa H
Infect Immun; 1982 Dec; 38(3):848-54. PubMed ID: 6295949
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramyl peptides and bacterial lipopolysaccharides with bovine serum albumin.
Ogawa T; Kotani S; Shimauchi H
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):117-25. PubMed ID: 3713372
[TBL] [Abstract][Full Text] [Related]
8. Anti-infectious activity of liposomal muramyl dipeptides in immunodeficient CBA/N mice.
Phillips NC; Chedid L
Infect Immun; 1987 Jun; 55(6):1426-30. PubMed ID: 3553001
[TBL] [Abstract][Full Text] [Related]
9. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats.
Kohashi O; Kohashi Y; Shigematsu N; Ozawa A; Kotani S
Lab Invest; 1986 Sep; 55(3):337-46. PubMed ID: 3489128
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice.
Fraser-Smith EB; Matthews TR
Infect Immun; 1981 Dec; 34(3):676-83. PubMed ID: 7333666
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramylpeptides and bacterial lipopolysaccharides with bovine serum albumin.
Ogawa T; Kotani S; Shimauchi H
Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):19-26. PubMed ID: 3702542
[TBL] [Abstract][Full Text] [Related]
12. Uveitis induction in the rabbit by muramyl dipeptides.
Waters RV; Terrell TG; Jones GH
Infect Immun; 1986 Mar; 51(3):816-25. PubMed ID: 3949381
[TBL] [Abstract][Full Text] [Related]
13. Suppression of Sendai virus growth by treatment with N alpha-acetylmuramyl-L-alanyl-D-isoglutaminyl-N epsilon-stearoyl-L-lysine in mice.
Ishihara C; Mizukoshi N; Iida J; Kato K; Yamamoto K; Azuma I
Vaccine; 1987 Dec; 5(4):295-301. PubMed ID: 2448969
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds.
Azuma I; Sugimura K; Yamawaki M; Uemiya M; Kusumoto S; Okada S; Shiba T; Yamamura Y
Infect Immun; 1978 Jun; 20(3):600-7. PubMed ID: 97234
[TBL] [Abstract][Full Text] [Related]
15. Biological activity of anomeric pairs of lipophilic glycosides of N-acetylmuramyl-L-alanyl-D-isoglutamine.
Kalyuzhin OV; Zemlyakov AE; Kalina NG; Mulik EL; Kuzovlev FN; Makarova OV
Bull Exp Biol Med; 2008 May; 145(5):623-5. PubMed ID: 19145298
[TBL] [Abstract][Full Text] [Related]
16. Effect of muramyl dipeptide and its stearoyl derivatives on resistance to Sendai virus infection in mice.
Ishihara C; Hamada N; Yamamoto K; Iida J; Azuma I; Yamamura Y
Vaccine; 1985 Dec; 3(5):370-4. PubMed ID: 2417426
[TBL] [Abstract][Full Text] [Related]
17. Elevation by muroctasin of the serum level of the complement subcomponent C1q in mice and of its biosynthesis by cultured mouse peritoneal macrophages.
Endo N; Okuda T; Osada Y; Zen-yoji H
Arzneimittelforschung; 1990 Jan; 40(1):58-61. PubMed ID: 2340001
[TBL] [Abstract][Full Text] [Related]
18. [Muramyl dipeptide and its synthetic analog as possible inducers of interleukin-2 production].
Malaĭtsev VV; Bogdanov IM; Sukhikh GT; Andronova TM
Biull Eksp Biol Med; 1985 Aug; 100(8):221-3. PubMed ID: 3875372
[TBL] [Abstract][Full Text] [Related]
19. Activation of mouse peritoneal adherent cells with N-acyl muramyl dipeptide derivatives.
Nishimura K; Okumura H; Saiki I; Okuyama H; Azuma I
Infect Immun; 1985 Mar; 47(3):665-9. PubMed ID: 3882562
[TBL] [Abstract][Full Text] [Related]
20. Effect of N alpha-acetylmuramyl-L-alanyl-D-isoglutaminyl-N epsilon-stearoyl- L-lysine on resistance to herpes simplex virus type-1 infection in cyclophosphamide-treated mice.
Ishihara C; Iida J; Mizukoshi N; Yamamoto N; Yamamoto K; Kato K; Azuma I
Vaccine; 1989 Aug; 7(4):309-13. PubMed ID: 2554602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
